Zobrazeno 1 - 10
of 42
pro vyhledávání: '"E F Wouters"'
Autor:
P Alter, K Kahnert, F C Trudzinski, R Bals, H Watz, T Speicher, S Söhler, S Andreas, T Welte, K F Rabe, E F Wouters, C Lange, H Wirtz, J H Ficker, C F Vogelmeier, R A Jörres
Publikováno v:
05.02 - Monitoring airway disease.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc8f85cb3bc51361d9d5bc0ca1847bcf
https://doi.org/10.1183/13993003.congress-2022.340
https://doi.org/10.1183/13993003.congress-2022.340
Autor:
A Ofenheimer, M Breyer, E F Wouters, C Schiffers, S Hartl, O C Burghuber, F Krach, F M Franssen, T Mraz, P Puchhammer, R Breyer-Kohansal
Publikováno v:
09.01 - Respiratory function technologists/scientists.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::232be89b6bee8f1efa088404cf1d831f
https://doi.org/10.1183/13993003.congress-2022.341
https://doi.org/10.1183/13993003.congress-2022.341
Autor:
Emiel F.M. Wouters, Frits M.E. Franssen, Martijn A. Spruit, Daisy J.A. Janssen, Lowie E.G.W. Vanfleteren, Ingrid M. L. Augustin, Sarah Houben-Wilke, Birgit B. R. E. F. Wouters, Rosita A. H. Stevens
Publikováno v:
Expert Review of Respiratory Medicine, 11(12), 919-924. Routledge/Taylor & Francis Group
Introduction: The independent and central role of the patient with a complex chronic respiratory disease in targeted, personalized disease management strategies is becoming increasingly important. Patients are the ones living with the disease and are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5414ba9e32e486ed10c8a19e52cebc64
https://doi.org/10.1080/17476348.2017.1392242
https://doi.org/10.1080/17476348.2017.1392242
Autor:
Lowie E.G.W. Vanfleteren, Ingrid M. L. Augustin, Sarah Houben-Wilke, Frits M.E. Franssen, Birgit B. R. E. F. Wouters, Emiel F.M. Wouters
Publikováno v:
European Respiratory Review, Vol 27, Iss 147 (2018)
This review summarises ongoing developments in personalised medicine and individualised medicine in chronic obstructive pulmonary disease (COPD). Currently applied classification systems largely ignore the complexity and heterogeneity of the COPD syn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09c98ce8a8b55453b92112d79b361976
http://err.ersjournals.com/content/27/147/170125.full
http://err.ersjournals.com/content/27/147/170125.full
Publikováno v:
European Respiratory Journal. 4:1101-1105
In a placebo controlled study the effects of 6 weeks' treatment with inhaled budesonide (1.6 mg daily) on the impedance of the respiratory system, spirometry and symptom scores were evaluated in 35 patients with chronic bronchitis with forced expirat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b46317abf216568973826051858eb309
https://doi.org/10.1183/09031936.93.04091101
https://doi.org/10.1183/09031936.93.04091101
Publikováno v:
Chest, 124(5), 1733-1742. Elsevier
A role for anabolic steroids in the rehabilitation of patients with COPD? A double-blind, placebo-controlled, randomized trial. Creutzberg EC, Wouters EF, Mostert R, Pluymers RJ, Schols AM. Department of Pulmonology, University Hospital Maastricht, M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::181cef72a38bb7c5724904d8ff90f2a6
https://cris.maastrichtuniversity.nl/en/publications/b8603fb6-0222-4c5c-9e89-8e7db9d592ca
https://cris.maastrichtuniversity.nl/en/publications/b8603fb6-0222-4c5c-9e89-8e7db9d592ca
Evaluation for sleep apnea in patients with Ehlers-Danlos syndrome and Marfan: a questionnaire study
Publikováno v:
Clinical genetics. 60(5)
Sleep complaints are frequently reported by patients with Marfan and Ehlers-Danlos syndrome (EDS). We examined the exact nature of sleep complaints in these patients. A representative sample of Marfan and EDS patients responded to a general sleep que
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::748793abded44411818e4135cc3bb2a0
https://pubmed.ncbi.nlm.nih.gov/11903337
https://pubmed.ncbi.nlm.nih.gov/11903337
Autor:
E F, Wouters
Publikováno v:
Pediatric pulmonology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b82d732d7d787739e1bddacd14975120
https://pubmed.ncbi.nlm.nih.gov/11886135
https://pubmed.ncbi.nlm.nih.gov/11886135
Publikováno v:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 18(1)
Sarcoidosis is an inflammatory disorder of unknown origin. The nuclear regulatory factor-kappaB (NF-kappaB) appears to play a key role in immune and inflammatory processes such as asthma, rheumatoid arthritis and inflammatory bowel disease. We hypoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::579ac262a8b6da11be45fb4b5f287165
https://pubmed.ncbi.nlm.nih.gov/11354547
https://pubmed.ncbi.nlm.nih.gov/11354547
Publikováno v:
Pediatric pulmonology. 31(1)
SUMMARY. In this prospective open study of 14 children with cystic fibrosis (CF), we evaluated the effect of 1 year adjuvant therapy with lansoprazole, a proton pump inhibitor (PPI), on growth, fecal fat loss, body composition and lung function. Only
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37f1a743ae6ea1379521f680ed891b5c
https://pubmed.ncbi.nlm.nih.gov/11180676
https://pubmed.ncbi.nlm.nih.gov/11180676